Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area jak stat signaling egfr'

Search results for: 'research area jak stat signaling egfr'

Items 41-50 of 153

Page
per page
  1. PD184352 (CI-1040)
    A1792 PD184352 (CI-1040)
    Target: MEK
    Summary: Selective MEK inhibitor
      ≥47.9 mg/mL
  2. SB202190 (FHPI)
    A1632 SB202190 (FHPI)
     5 Citation
    Target: p38
    Summary: P38 MAPK inhibitor
  3. U0126-EtOH
    A1337 U0126-EtOH
     10 Citation
    Target: MEK
    Summary: MEK1/2 inhibitor
      ≥21.33 mg/mL
  4. LY2228820
    A5566 LY2228820
     1 Citation
    Target: p38
    Summary: P38 MAP kinase inhibitor
      ≥30.65 mg/mL
  5. CC-930
    A3288 CC-930
    Target: JNK
    Summary: JNK inhibitor,potent and selective
      Soluble in DMSO
  6. Trametinib (GSK1120212)
    A3018 Trametinib (GSK1120212)
     7 Citation
    Target: MEK
    Summary: MEK1 and MEK2 inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL
  7. CHIR-99021 (CT99021) HCl
    A8396 CHIR-99021 (CT99021) HCl
    Target: GSK-3
    Summary: GSK-3α/β inhibitor
      ≥25.1 mg/mL
  8. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     2 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
      ≥23.27 mg/mL
  9. Gefitinib hydrochloride
    A3433 Gefitinib hydrochloride
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; ≥4.28 mg/mL
  10. XAV-939
    A1877 XAV-939
     1 Citation
    Target: TNKS
    Summary: Tankyrase 1/2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL

Items 41-50 of 153

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 152item
  2. Natural Products 1 item
Specificity
  1. Selective 103item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 9item
  2. Irreversible 6item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 9item
  4. PI3K 13item
  5. Raf 8item
  6. Aurora Kinases 1 item
  7. mTOR 8item
  8. Androgen Receptors 1 item
  9. FLT3 2item
  10. GSK-3 6item
  11. P-glycoprotein (P-gp) 1 item
  12. VEGFR 10item
  13. PDGFR 4item
  14. Phosphodiesterases (PDEs) 1 item
  15. p38 4item
  16. PKB 1 item
  17. JNK 2item
  18. Bcr-Abl 1 item
  19. MEK 4item
  20. PORCN 1 item
  21. FGFR 5item
  22. Nrf2 1 item
  23. GABAB Receptors 1 item
  24. Smoothened 1 item
  25. MET 1 item
  26. Src 3item
  27. Trk Receptors 1 item
  28. NMDA Receptors 1 item
  29. STAT 7item
  30. EGFR 21item
  31. Hedgehog 1 item
  32. BMP and Other Activin Receptors 2item
  33. JAK 17item
  34. Syk 2item
  35. DNA-PK 1 item
  36. HSP90 1 item
  37. TNKS 1 item
  38. ErbB 5item
  39. Toll-like receptors (TLRs) 1 item
  40. ERK 2item
  41. c-MET 1 item
  42. PKC 7item
  43. HER2 3item
  44. Melanocortin (MC) Receptors 1 item
  45. ALK 2item
  46. PKG 1 item
  47. PKA 4item
  48. Fatty-acid-binding proteins (FABPs) 1 item
  49. RSK 1 item
  50. Histamine H1 Receptors 1 item
  51. MNK 1 item
  52. NO Donors / Precursors 1 item
  53. IL Receptors 1 item
  54. AChE 1 item
  55. Insulin Receptors 1 item
  56. IRG-1R 1 item
  57. BACE 1 item
  58. c-RET 1 item
  59. p70 rsk 1 item
  60. insulin 1 item
  61. Smoothened receptor 1 item
  62. Antibiotic 1 item
  63. ErbB-2 1 item
  64. Prk 1 item
  65. ICAM 1 item
  66. Rho 1 item
  67. TYK2 2item
  68. MUSK 1 item
  69. MAP3K 1 item
  70. Thrombin Receptor 1 item
  71. prolactin secretion 1 item
  72. gonadotropin release 1 item
  73. TRPC channel 1 item
  74. FKBP 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 3item
  3. Bladder Cancer 2item
  4. Breast Cancer 27item
  5. Cancer 102item
  6. Cervical Cancer 2item
  7. Colon Cancer 10item
  8. Colon Carcinoma 1 item
  9. Colorectal Cancer 11item
  10. Glioblastoma 11item
  11. Glioma 3item
  12. Heart Failure 1 item
  13. Hepatocellular Carcinoma 1 item
  14. HIV Infections 1 item
  15. Immunological Diseases 1 item
  16. Inflammatory Bowel Disease 1 item
  17. Leukemia 9item
  18. Liver Cancer 2item
  19. Lung Cancer 8item
  20. Lymphoma 3item
  21. Melanoma 6item
  22. Multiple Myeloma 2item
  23. Myelofibrosis 1 item
  24. Myeloma 1 item
  25. Neuroblastoma 2item
  26. Non-small Cell Lung Cancer 6item
  27. Ovarian Cancer 8item
  28. Pancreatic Cancer 11item
  29. Pancreatic Carcinoma 2item
  30. Prostate Cancer 14item
  31. Psoriasis 1 item
  32. Pulmonary Arterial Hypertension 1 item
  33. Pulmonary Fibrosis 1 item
  34. Renal Cancer 1 item
  35. Renal Cell Carcinoma 1 item
  36. Rheumatoid Arthritis 4item
  37. Thyroid Cancer 2item
  38. Type 2 Diabetes 2item